معرفی
Prof. Gregor Hasler is a Professor of Psychiatry at the University of Bern, affiliated with the University Clinics UPD. His research focuses on psychedelic therapy, neuroplasticity, mood disorders, and mental health outcomes during global health crises. He leads the COH-FIT study investigating pandemic impacts on well-being, and has pioneered work on hallucinogen rating scales and ketamine's effects on self-schema. His interdisciplinary approach bridges pharmacology, neuroimaging, and clinical psychology.
- Education: Medical degree from the University of Fribourg (assumed from email domain)
- Key Roles: Department Head at UPD's Psychiatry & Psychotherapy unit, Principal Investigator in psychedelic research
- Labs/Teams: Co-Director of the Neuroplasticity Research Group, Member of the Swiss Society for Bipolar Disorders (SSTB)
Research interests include neuroprotective mechanisms in psychiatric disorders, biomarkers for bipolar disorder, and the gut-brain axis. His neuroimaging studies explore glutamate pathways in depression and prefrontal brain chemistry in mood disorders. Recent work addresses psychedelic-induced neuroplasticity and microdosing safety.
Publications emphasize translational research, with over 150 peer-reviewed articles since 2000. Notable contributions include:
- Validation of psychedelic side effects inventories
- Meta-analyses on lithium prescription patterns
- Neuropsychiatric imaging protocols for mood disorders
Awards: None explicitly listed, though SSTB guidelines contributions suggest professional recognition.
